These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22665526)

  • 1. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.
    De Keersmaecker K
    Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526
    [No Abstract]   [Full Text] [Related]  

  • 2. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-ALL paradox in cancer.
    Hoang T; Hoang T
    Nat Med; 2010 Nov; 16(11):1185-6. PubMed ID: 21052064
    [No Abstract]   [Full Text] [Related]  

  • 6. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
    Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
    Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
    Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K
    Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
    Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
    Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
    Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
    Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
    Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
    Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
    Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
    Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
    Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
    Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
    Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
    Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
    Riz I; Hawley TS; Johnston H; Hawley RG
    Br J Haematol; 2009 Apr; 145(1):140-3. PubMed ID: 19133982
    [No Abstract]   [Full Text] [Related]  

  • 17. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia.
    Kleppe M; Soulier J; Asnafi V; Mentens N; Hornakova T; Knoops L; Constantinescu S; Sigaux F; Meijerink JP; Vandenberghe P; Tartaglia M; Foa R; Macintyre E; Haferlach T; Cools J
    Blood; 2011 Jun; 117(26):7090-8. PubMed ID: 21551237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
    Rakowski LA; Lehotzky EA; Chiang MY
    PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of leukemia development caused by PTEN loss.
    Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1409-14. PubMed ID: 21212363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.